Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

David Michael Williams, Executive Vice President and Chief Information & Digital Officer at Merck (NSE:PROR) & Co., Inc.

Three stocks that may be underrated options for dividend investors to consider today are PepsiCo ( PEP 0.41%), United Parcel ...

Co's stock has reached a 52-week low, dipping to $85.71. This downturn reflects a significant shift from the previous year, with the pharmaceutical giant experiencing a 1-year change of -31.59%.

德国制药巨头默克公司（Merck KGaA）确认，正在就收购美国生物制药公司SpringWorks Therapeutics进行深入谈判，后者是一家专门研究罕见疾病和癌症的公司。 默克当地时间周一晚间表示，双方尚未达成具有法律约束力的协议，也不确定是否会达成任何交易。该公司 ...

Sonoco Products (NYSE:SON – Get Free Report) is expected to be releasing its earnings data after the market closes on Tuesday, February 18th. Analysts expect Sonoco Products to post earnings of $1.18 ...

Investment analysts at Wedbush cut their FY2025 earnings per share estimates for Advanced Micro Devices in a research report issued on Wednesday, February 5th. Wedbush analyst M. Bryson now expects ...

Die Merck KGaA befindet sich in fortgeschrittenen Verhandlungen zum Kauf des amerikanischen Krebsspezialisten SpringWorks ...

智通财经获悉，默克公司 (Merck KGaA)表示，收购美国癌症和罕见疾病制药公司SpringWorks Therapeutics ...

SpringWorks Therapeutics stock surged over Monday after a report from Reuters that German medical tech giant Merck KGaA could be close to acquiring the company.